- Home
- HRTX vs ACB Comparison
HRTX vs ACB Comparison
Compare HRTX & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HRTX | ACB |
|---|---|---|
| Founded | 1983 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Pharmaceuticals and Biotechnology |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 265.9M | 250.1M |
| IPO Year | 2007 | 2016 |
Fundamental Metrics
Financial Performance| Metric | HRTX | ACB |
|---|---|---|
| Price | $1.20 | $3.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 982.9K |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $154,904,000.00 | N/A |
| Revenue This Year | $13.08 | $6.89 |
| Revenue Next Year | $20.42 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.36 | N/A |
| 52 Week Low | $1.00 | $3.28 |
| 52 Week High | $2.68 | $6.67 |
Technical Indicators
Market Signals| Indicator | HRTX | ACB |
|---|---|---|
| Relative Strength Index (RSI) | 45.92 | 40.49 |
| Support Level | $1.07 | $3.28 |
| Resistance Level | $1.37 | $5.69 |
| Average True Range (ATR) | 0.09 | 0.15 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 51.79 | 37.93 |
Price Performance
Historical ComparisonAbout HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About ACB Aurora Cannabis Inc.
Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.